These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21189133)

  • 1. Metabolism of benzodiazepine and non-benzodiazepine anxiolytic-hypnotic drugs: an analytical point of view.
    Mandrioli R; Mercolini L; Raggi MA
    Curr Drug Metab; 2010 Nov; 11(9):815-29. PubMed ID: 21189133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine metabolism: an analytical perspective.
    Mandrioli R; Mercolini L; Raggi MA
    Curr Drug Metab; 2008 Oct; 9(8):827-44. PubMed ID: 18855614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of anxiolytics and hypnotics: benzodiazepines, buspirone, zoplicone, and zolpidem.
    Chouinard G; Lefko-Singh K; Teboul E
    Cell Mol Neurobiol; 1999 Aug; 19(4):533-52. PubMed ID: 10379424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).
    Greenblatt DJ; Harmatz JS; Shader RI
    Clin Pharmacokinet; 1991 Sep; 21(3):165-77. PubMed ID: 1684924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
    Griebel G; Perrault G; Sanger DJ
    J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and drug interactions of the sedative hypnotics.
    Wang JS; DeVane CL
    Psychopharmacol Bull; 2003; 37(1):10-29. PubMed ID: 14561946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorelaxant effects of benzodiazepines, non-benzodiazepine sedative-hypnotics, and tandospirone on isolated rat arteries.
    Kagota S; Morikawa K; Ishida H; Chimoto J; Maruyama-Fumoto K; Yamada S; Shinozuka K
    Eur J Pharmacol; 2021 Feb; 892():173744. PubMed ID: 33220270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based study.
    Bénard-Laribière A; Noize P; Pambrun E; Bazin F; Verdoux H; Tournier M; Bégaud B; Pariente A
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):162-169. PubMed ID: 27807907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects.
    Dinis-Oliveira RJ
    Drug Metab Rev; 2017 Nov; 49(4):451-463. PubMed ID: 28903606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic.
    Goa KL; Heel RC
    Drugs; 1986 Jul; 32(1):48-65. PubMed ID: 2874974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiolytics, Sedatives, and Hypnotics Prescribed by Dentists in Brazil in 2010.
    Lino PA; Martins MAP; Silva MESE; de Abreu MHNG
    Biomed Res Int; 2017; 2017():2841549. PubMed ID: 28638826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014.
    Kurko T; Saastamoinen LK; Tuulio-Henriksson A; Taiminen T; Tiihonen J; Airaksinen M; Hietala J
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):674-682. PubMed ID: 29726630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.
    Kintz P; Villain M; Concheiro M; Cirimele V
    Forensic Sci Int; 2005 Jun; 150(2-3):213-20. PubMed ID: 15944062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pharmacokinetics of anxiolytic drugs.
    Altamura AC; Moliterno D; Paletta S; Maffini M; Mauri MC; Bareggi S
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):423-40. PubMed ID: 23330992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
    Hesse LM; von Moltke LL; Greenblatt DJ
    CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dispensing Patterns of Anxiolytics and Sedative-Hypnotics: A Feasibility Study Comparing Datasets from a Developed and a Developing Country (Australia and South Africa).
    Kairuz T; Truter I; Rossato L; Pudmenzky A
    Curr Drug Saf; 2017; 12(1):57-61. PubMed ID: 28067180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzodiazepine hypnotics: sorting the pharmacokinetic facts.
    Greenblatt DJ
    J Clin Psychiatry; 1991 Sep; 52 Suppl():4-10. PubMed ID: 1680125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of new hypnotic drugs in rats trained to discriminate ethanol.
    Sanger DJ
    Behav Pharmacol; 1997 Aug; 8(4):287-92. PubMed ID: 9832988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a fast ionic liquid-based dispersive liquid-liquid microextraction procedure combined with LC-MS/MS analysis for the quantification of benzodiazepines and benzodiazepine-like hypnotics in whole blood.
    De Boeck M; Missotten S; Dehaen W; Tytgat J; Cuypers E
    Forensic Sci Int; 2017 May; 274():44-54. PubMed ID: 28094153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle relaxants for pain management in rheumatoid arthritis.
    Richards BL; Whittle SL; Buchbinder R
    Cochrane Database Syst Rev; 2012 Jan; 1():CD008922. PubMed ID: 22258993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.